AzTrials
AzTrials

Highlight the Most Important Preventable Factors That May Help Decrease Rate of Ceaseran Section in EgyptNCT06757790

Predictors of Primary Ceaseran Section At Women Health Hospital

An observational study of Highlight the Most Important Preventable Factors That May Help Decrease Rate of Ceaseran Section in Egypt, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Predictors of primary Ceaseran section Highlight the most important preventable risk factors that may help decrease rate of ceaseran section in Egypt Read more about this study

Who is it for?
Any age, women only
What is being tested?
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
How many people
298 participants
Where
No sites listed yet
Study dates
30 Dec 2024to 30 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study will be conducted at Women's Health Hospital in Assiut University, Department of Obstetrics and Gynecology. divided into 2 groups :females had primary ceaseran section for case and primary vaginal delivery for control group

  1. Inclusion criteria:
  2. All pregnant women underwent primary ceaseran section
  3. All primiparous women delivered vaginally b. Exclusion criteria: (1) any women done previous one or more ceaseran section before (2) All pregnant women delivered vaginally before more than one time (2) women had previous uterine scar as hysterectomy, myomectomy (4) any female refused to participate

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Mina Mikhail Mina Mikhail labib melk contact

+201069064059

drminamikhail13@gmail.com

About this study

Predictors of primary Ceaseran section Highlight the most important preventable risk factors that may help decrease rate of ceaseran section in Egypt

Read the detailed description

A caesarean section is a surgical procedure in which incisions are made through a woman's Anterior abdominal and uterus to deliver the baby. (1) It is performed whenever abnormal conditions are making normal delivery difficult and endangering the life of the mother or the baby. Cesarean section is the most common obstetric surgical procedure worldwide. Although low cesarean delivery rates are associated with an increase in adverse events, higher-than-institution cesarean delivery rates have been shown not to improve maternal or neonatal outcomes but to cause additional costs and unnecessary interventions (2). There is a global concern that the number of cesarean deliveries is increasing worldwide, regardless of health status, age, race, or gestational age. (3) A Cesarean section of can only effectively save the life of mother and child when it is medically justified (4). For mothers or infants who do not require a Cesarean section, there is no advantage to having it. (5) Recently, it has been reported that the rate of cesarean delivery in Egypt is increasing. (6) All women undergoing indicated or voluntary Cesarean section are at risk of various complications and negative consequences for future pregnancies.(7) Therefore, avoiding unnecessary Cesarean section must be a top priority.(8) An increase in Cesarean has been observed to be among women of all ages and race/ethnicities, in every state, and is thought to be due to; decrease in Vaginal Births after Caesarean Section (VBAC), decreased vaginal births of breech presentation, and increased prevalence of high-risk pregnancies such as advanced maternal age and some subjective indications during labour such as non-reassuring fetal status and arrest of dilation

Being tested
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran sectionOther

    A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section

Study groups in NCT06757790
Study groupRoleWhat they receive
Primary ceaseran section womenA comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
Receives: Other: A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
Primary vaginally delivery womenA comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
Receives: Other: A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Identify the risk factors of primary ceaseran section

    Identify the risk factors of primary ceaseran section and it's predictors among women seeking delivery care in women health hospital

    Measured: Baseline

Secondary outcomes (1)
  1. Highlight the most important preventable factors of ceaseran section

    Highlight the most important preventable factors that may help decrease rate of ceaseran section in Egypt

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jan 2025
  2. Study start30 Dec 2024 (estimated)
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
298 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06757790
Sponsor's protocol ID
Predictors of ceaseran section
Status last verified
Dec 2024
First submitted
26 Dec 2024
Last updated
3 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Highlight the Most Important Preventable Factors That May Help Decrease Rate of Ceaseran Section in Egypt, run by Assiut University.

The full registered description is in the About this study section and the official record.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mina Mikhail Mina Mikhail labib melk (+201069064059, drminamikhail13@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Identify the risk factors of primary ceaseran section (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in